Fast urinary screening for paracetamol using on-line microwave assisted hydrolysis and spectrophotometric detection.

A fully automated urinary screening system for paracetamol and its metabolites is proposed. The method comprises on-line acid microwave assisted hydrolysis of the drug to p-aminophenol followed by reaction with o-cresol in alkaline medium. The indophenol blue dye formed can be continuously monitored at 620 nm. The detection limit achieved, 0.1 microgram ml-1, allows a high dilution of the samples, thus reducing potential interferences from the sample matrix (mainly protein degradation during urine hydrolysis). The proposed screening system also possesses an adequate selectivity, as the major interferent, epinephrine, is tolerated at concentrations higher than those that could be found in the positive urine samples. The reproducibility, expressed as relative standard deviation, was 3.0% and the sample frequency 20 h-1. The reliability of the method was established at five concentrations (between 0.5 and 4 times the detection limit). Finally, it was applied to the screening of several human urine samples. The results obtained were compared with those provided by batch acid hydrolysis, and were similar in all instances.

[1]  J. Hart,et al.  Rapid detection of paracetamol using a disposable, surface-modified screen-printed carbon electrode , 1994 .

[2]  Miguel Valcárcel,et al.  Sample screening systems in analytical chemistry , 1999 .

[3]  J. Critchley,et al.  The estimation of paracetamol and its major metabolites in both plasma and urine by a single high-performance liquid chromatography assay. , 1994, Journal of pharmaceutical and biomedical analysis.

[4]  J P Shockcor,et al.  Combined HPLC, NMR spectroscopy, and ion-trap mass spectrometry with application to the detection and characterization of xenobiotic and endogenous metabolites in human urine. , 1996, Analytical chemistry.

[5]  J. Millership,et al.  Assay of paracetamol and its metabolites in urine, plasma and saliva of children with chronic liver disease. , 1995, Journal of pharmaceutical and biomedical analysis.

[6]  T. Atkinson,et al.  Development of an enzyme-based assay for acetaminophen. , 1984, Analytical biochemistry.

[7]  I. Wilson,et al.  On-flow identification of metabolites of paracetamol from human urine using directly coupled CZE–NMR and CEC–NMR spectroscopy , 1998 .

[8]  P. Vadgama,et al.  Direct electrochemical determination of paracetamol in plasma , 1993 .

[9]  S. Garrigues,et al.  Flow injection spectrophotometric determination of paracetamol in pharmaceuticals by means of on-line microwave-assisted hydrolysis and reaction with 8-hydroxyquinoline (8-quinolinol) , 1996 .

[10]  Mayer,et al.  More on interference of N-acetylcysteine in measurement of acetaminophen , 1998, Clinical chemistry.

[11]  J. Ray,et al.  A rapid urinary screen for acetaminophen modified to avoid false-negative results. , 1987, Clinical chemistry.

[12]  M. Alda,et al.  A validated high-performance liquid chromatographic method for the determination of paracetamol and its major metabolites in urine , 1995 .

[13]  M. Sundaresan,et al.  HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC DETERMINATION OF ACETAMINOPHEN IN HUMAN BLOOD PLASMA USING ELECTROCHEMICAL DETECTION , 1998 .

[14]  R. Avidad,et al.  Spectrofluorimetric determination of paracetamol in pharmaceuticals and biological fluids. , 1995, Journal of pharmaceutical and biomedical analysis.

[15]  A. Dasgupta,et al.  Microwave-induced rapid hydrolysis of acetaminophen and its conjugates in urine for emergency toxicological screen. , 1993, Clinical chemistry.

[16]  E. Wang,et al.  CATALYTIC-OXIDATION AND FLOW DETECTION OF ACETAMINOPHEN AT A DICYANOBIS(1,10-PHENANTHROLINE)IRON(II)-MODIFIED ELECTRODE , 1994 .